$IMRX
Immuneering Corporation Class A Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$4.50
▲+0.45%+$0.020
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateImmuneering Corporation Class A Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is IMRX up today? It is at $4.50 (+0.00%), and our scanner flagged it 44 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment IMRX spikes, and full due diligence on IMRX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $IMRX 44 times in the last 30 days. Create a free account to track $IMRX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on IMRX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for IMRX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Zeskind Benjamin J. Officer | Bought (open market) | +2K | added 0.1% | 2.32M | $11K at $4.56 | Jun 23, 26 |
Hall Brett Matthew Officer | Bought (open market) | +6K 0.02% of company | added 1.6% | 383K | $25K at $4.15 | Jun 15, 26 |
Neufeld Leah R Officer | Acquired (grant/award) | +4K 0.01% of company | added 14% | 30K | $16K at $4.29 | Mar 13, 26 |
Brakewood Harold Eugene Officer | Bought (open market) | +5K 0.02% of company | added 91% | 11K | $25K at $4.76 | Jan 16, 26 |
Hall Brett Matthew Officer | Bought (open market) | +2K | added 0.6% | 376K | $11K at $4.57 | Jan 15, 26 |
Schall Thomas J. Director | Bought (open market) | +22K 0.08% of company | added 41% | 75K | $101K at $4.67 | Jan 15, 26 |
Neufeld Leah R Officer | Bought (open market) | +3K 0.01% of company | added 11% | 26K | $11K at $4.15 | Jan 13, 26 |
Feinberg Peter Director | Bought (open market) | +20K 0.08% of company | added 2.0% | 1.00M | $87K at $4.35 | Jan 12, 26 |
Feinberg Peter Director | Bought (open market) | +8K 0.03% of company | added 5.0% | 157K | $50K at $6.67 | Oct 3, 25 |
Bookman Michael Officer | Bought (open market) | +1K | added 26% | 5K | $7K at $6.83 | Oct 1, 25 |
Neufeld Leah R Officer | Bought (open market) | +800 | added 3.5% | 23K | $5K at $6.38 | Oct 1, 25 |
Morales Mallory Officer | Bought (open market) | +300 | added 1.1% | 28K | $2K at $6.39 | Oct 1, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on IMRX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for IMRX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
IMRX last traded at $4.50, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Immuneering Corporation Class A Common Stock (IMRX) is next expected to report earnings on Wednesday, November 11, 2026, about 52 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The IMRX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged IMRX 44 times in the last 30 days.
IMRX (Immuneering Corporation Class A Common Stock) trades on XNAS, with a market cap of about $116M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge IMRX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$IMRX discussion
Sign in to ask a question or join the discussion.